Trials / Completed
CompletedNCT03807505
Erector Spinae Plane Versus Interscalene Blocks for Shoulder Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is the evaluation of erector spinae plane (ESP) blocks as an alternative to interscalene brachial plexus nerve blocks for rotator cuff repair and total shoulder arthroplasty procedures. Currently, single shot interscalene nerve blocks are performed for rotator cuff repair surgeries, and interscalene nerve catheters are placed for total shoulder arthroplasty surgeries. Erector spinae plane blocks are commonly used as part of the anesthetic plan for other surgeries, but less so for shoulder surgeries. The investigators would like to study whether an ESP block can provide similar pain control compared to an interscalene nerve block, with less risk of upper extremity motor block and phrenic nerve block.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Interscalene brachial plexus nerve block | An interscalene brachial plexus nerve block (single shot or catheter, depending on surgical procedure) will be placed under ultrasound guidance and all patients will receive 10cc 0.5% ropivacaine during block placement. Patients with a nerve catheter will receive a bolus of 5cc 0.5% ropivicaine postoperatively, on arrival to the recovery unit. |
| PROCEDURE | Erector spinae plane block | An erector spinae plane block (single shot or catheter, depending on surgical procedure) will be placed under ultrasound guidance and all patients will receive 10cc 0.5% ropivacaine during block placement. Patients with a nerve catheter will receive a bolus of 5cc 0.5% ropivicaine postoperatively, on arrival to the recovery unit. |
Timeline
- Start date
- 2019-06-13
- Primary completion
- 2019-11-22
- Completion
- 2019-12-31
- First posted
- 2019-01-17
- Last updated
- 2020-03-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03807505. Inclusion in this directory is not an endorsement.